Gregory OD Smith Joins SHINE BOD

2017-08-01T08:31:20+00:00

February 13th, 2017 – Janesville, WI – SHINE Medical Technologies, Inc. (SHINE), a company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that Gregory Smith will join its Board of Directors. The appointment comes as the company prepares to build its facility in Janesville, Wisconsin, after receiving its construction permit from the U.S. Nuclear Regulatory Commission last year. The SHINE facility will produce molybdenum-99 (moly‑99) and other medical isotopes.

Gregory OD Smith Joins SHINE BOD 2017-08-01T08:31:20+00:00

SHINE Awarded $20.9M DOE/NNSA Phase II

2017-08-01T08:35:37+00:00

December 12, 2016 - SHINE Medical Technologies announced today that it has been awarded $10 million from the U.S. Department of Energy’s National Nuclear Security Administration (DOE/NNSA) as part of a $20.9 million cooperative agreement.

SHINE Awarded $20.9M DOE/NNSA Phase II 2017-08-01T08:35:37+00:00

SHINE to Move HQ to Janesville, Wisconsin

2017-10-16T08:50:08+00:00

September 23, 2016 - SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced plans to move its headquarters from Monona to downtown Janesville, Wisconsin late this year.

SHINE to Move HQ to Janesville, Wisconsin 2017-10-16T08:50:08+00:00

SHINE to Present at Mo-99 Topical Meeting

2017-08-01T08:36:30+00:00

September 6, 2016 - SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that the company has been invited to speak at the 2016 Mo-99 Topical Meeting hosted by the Department of Energy’s National Nuclear Security Administration (DOE/NNSA).

SHINE to Present at Mo-99 Topical Meeting 2017-08-01T08:36:30+00:00

NRC Issues SHINE Construction Permit

2017-10-16T08:36:46+00:00

February 25, 2016 - SHINE Medical Technologies, Inc., a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical tracers and cancer treatment elements, announced today that the U.S. Nuclear Regulatory Commission (NRC) has authorized issuance of the SHINE construction permit.

NRC Issues SHINE Construction Permit 2017-10-16T08:36:46+00:00

SHINE CEO Awarded Top Honors by UW

2017-08-01T08:54:46+00:00

January 11, 2016 - The University of Wisconsin-Madison College of Engineering has awarded Dr. Greg Piefer, founder and CEO of SHINE Medical Technologies, Inc. (SHINE) the Early-Career Achievement Award.

SHINE CEO Awarded Top Honors by UW 2017-08-01T08:54:46+00:00

SHINE Holds 2nd 2015 Community Meeting

2017-08-01T08:40:34+00:00

December 7, 2015 - SHINE invites the Janesville community to an update on the development of its medical isotope production facility. Since our last meeting in June, SHINE’s primary regulator, the Nuclear Regulatory Commission, has completed their safety and environmental reviews and recommended the approval of a Construction Permit for the SHINE facility.

SHINE Holds 2nd 2015 Community Meeting 2017-08-01T08:40:34+00:00

SHINE Achieves Major Milestone on Path to Construction Permit Approval

2017-07-31T18:53:28+00:00

October 26, 2015 - SHINE Medical Technologies, Inc., a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical tracers and cancer treatment elements, announced today that the staff of its primary regulator, the Nuclear Regulatory Commission (NRC), has completed their safety and environmental reviews and recommends approval of a Construction Permit for the SHINE facility.

SHINE Achieves Major Milestone on Path to Construction Permit Approval 2017-07-31T18:53:28+00:00